Rhythm Initiates Commercialisation of ColoSTAT
Filed with ASX · · 2 pages · English
Rhythm Biosciences Limited on 6ix
Story so far
Earlier from Rhythm Biosciences
- Appendix 4C and Market Update
- Appendix 4E
- Strategic partnership with Know Your Lemons Foundation
- ColoSTAT Kit Validation Completion and NATA Submission
- Placement Prospectus
Later from Rhythm Biosciences
- datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development
- Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting
- Quarterly Activities Report and Appendix 4C
- Rhythm Biosciences Signs Manufacturing Agreement
- ColoSTAT commercial deployment - First physician enrolled
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences